首页> 外文学位 >Phyllanthus urinaria treatment in experimental model of non -alcoholic steatohepatitis.
【24h】

Phyllanthus urinaria treatment in experimental model of non -alcoholic steatohepatitis.

机译:余甘菊在非酒精性脂肪性肝炎实验模型中的治疗。

获取原文
获取原文并翻译 | 示例

摘要

Non-alcoholic steatohepatitis (NASH) results from excessive accumulation of hepatic fat (steatosis) and oxidative stress. Therefore, inhibition of fatty acid cytotoxicity and liver inflammtary change is an important goal in the treatment of NASH. Phyllanthus urinaria, a herbal medicine, has been reported to have potential anti-oxidant property. We tested the effects of Phyllanthus urinaria on nutritional steatohepatitis both in vitro and in vivo, and determined the mechanism of its action.;Immortalized normal hepatocytes AML-12 or primary hepatocytes were cultured in control, and the methionine and choline deficient (MCD) culture medium in the presence or absence of Phyllanthus urinaria for 24 hours. Hepatocyte triglyceride contents, release of alanine aminotransferase, lipoperoxides and reactive oxygen species production were determined in the cell culture study. Age-matched wild-type C57BL/6 and diabetes db/db mice were fed control or MCD diet for 10 days with or without Phyllanthus urinaria. The levels of Hepatic steatosis, necroinflammation, triglycerides and oxidative stress were investigated. Hepatic expression of inflammatory factors and lipid regulatory mediators were assayed. The results demonstrated that Phyllanthus urinaria reduced steatosis and alanine aminotransferase (ALT) levels in culture of hepatocytes in a dose-dependent manner. Phyllanthus urinaria protected the livers against MCD-induced hepatic fat accumulation and steatohepatitis in mice. This effect was associated with repressed levels of hepatic lipid peroxides, reduced expression of cytochrome P450 (CYP) 2e1, pro-inflammatory tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), dampened activation of inflammatory C-jun N-teuninal kinase (JNK) and nuclear factor kappaB (NF-kappaB), increased expression of lipolytic Cyp4a10 and suppressed transcriptional activity of lipogenic CCAAT/enhancer binding protein beta (C/EBPbeta). Hepatic acyl co-enzyme A oxidase (ACO) that regulated hepatic beta-oxidation of fatty acid and other lipid regulators were not affected by Phyllanthus urinaria.;Our study indicated that Phyllanthus urinaria effectively prevented MCD-induced steatohepatitis. This effect were probably mediated through dampening oxidative stress, ameliorating inflammation and decreasing lipid accumulation. Phyllanthus urinaria deserves further evaluation for its potential therapeutic effect on NASH in humans.
机译:非酒精性脂肪性肝炎(NASH)是由肝脂肪过度堆积(脂肪变性)和氧化应激引起的。因此,抑制脂肪酸的细胞毒性和肝炎性改变是NASH治疗的重要目标。据报道,余甘草(Phyllanthus urinaria)是一种潜在的抗氧化剂。我们在体外和体内测试了余甘子子叶对营养性脂肪性肝炎的影响,并确定了其作用机理。;在对照中培养了未感染的正常肝细胞AML-12或原代肝细胞,并进行了蛋氨酸和胆碱缺乏(MCD)培养培养基中存在或不存在楠木24小时。在细胞培养研究中确定了肝细胞甘油三酸酯含量,丙氨酸氨基转移酶的释放,脂过氧化物和活性氧的产生。年龄匹配的野生型C57BL / 6和糖尿病db / db小鼠在有或没有小叶楠的情况下接受了对照或MCD饮食10天。研究了肝脂肪变性,坏死性炎症,甘油三酸酯和氧化应激的水平。测定了肝炎性因子和脂质调节介质的表达。结果表明,余甘子以剂量依赖的方式降低了肝细胞培养物中的脂肪变性和丙氨酸转氨酶(ALT)水平。余甘菊可保护肝脏免受MCD诱导的小鼠肝脏脂肪堆积和脂肪性肝炎的侵害。这种作用与肝脂质过氧化物水平的降低,细胞色素P450(CYP)2e1的表达降低,促炎性肿瘤坏死因子-α(TNF-α),白介素6(IL-6)的表达降低,炎性C的激活减弱有关jun N-teuninal激酶(JNK)和核因子kappaB(NF-kappaB),增加脂解性Cyp4a10的表达并抑制脂源性CCAAT /增强子结合蛋白beta(C / EBPbeta)的转录活性。调节脂肪酸的肝脏β-氧化的肝酰基辅酶A氧化酶(ACO)和其他脂质调节剂不受小叶楠的影响。;我们的研究表明,小叶楠有效地预防了MCD引起的脂肪性肝炎。这种作用可能是通过抑制氧化应激,减轻炎症和减少脂质堆积而介导的。余甘子对人类NASH的潜在治疗作用值得进一步评价。

著录项

  • 作者

    Shen, Bo.;

  • 作者单位

    The Chinese University of Hong Kong (Hong Kong).;

  • 授予单位 The Chinese University of Hong Kong (Hong Kong).;
  • 学科 Biology Molecular.;Health Sciences Alternative Medicine.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 142 p.
  • 总页数 142
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号